Pharmaceuticals

2025–2029 Multidrug Resistant Bacteria Market Outlook: Regional Trends and Growth Forecast

September 1, 2025 by Marketing Posting

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#What CAGR Is Anticipated for the Multidrug Resistant Bacteria Market Through 2029?#_x000D_

The market size of vyndaqel has witnessed rapid expansion in recent years. It is projected to escalate from $1.62 billion in 2024 to $1.9 billion in 2025, boasting a compound annual growth rate (CAGR) of 17.0%. The swell in growth during the historic period is credited to the rise in awareness of transthyretin amyloidosis, increased instances of the cardiomyopathy caused by transthyretin-mediated amyloidosis, a heightened emphasis on rare diseases, bolstered government support, an increase in clinical trials, and a growing elderly population._x000D_

_x000D_

The market size of vyndaqel is projected to experience swift expansion in the coming years, reaching “$3.58 billion in 2029 with a compound annual growth rate (CAGR) of 17.3%. The growth during the projected period is expected to be driven by a surge in investments in research and development, the escalating adoption of precision medicine, an increase in physician familiarity, widespread availability of diagnostic tools, and enhanced government initiatives. The forecast period also anticipates significant trends that include the provision of telemedicine facilities, strategic partnerships, advancements in genetic testing, the rise of digital health tools, and the progression of personalized medicine._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=21321&type=smp_x000D_

_x000D_

#What Market Forces Are Driving The Multidrug Resistant Bacteria Sector In 2025 And Beyond?#_x000D_

The rise in infectious diseases is anticipated to fuel the expansion of the multidrug-resistant bacteria market in the future. These diseases are caused by harmful microorganisms, including bacteria, viruses, fungi, or parasites. Multidrug-resistant bacteria are intrinsically linked with infectious diseases due to their capacity to trigger infections that are tough to cure with regular antibiotics. Such bacteria have evolved to resist numerous antibiotics, thereby reducing their vulnerability to the medicines typically used against bacterial infections. As per an article by the Centers for Disease Control and Prevention, a public health agency in the US, in November 2023, the count of tuberculosis patients in the USA saw an increase from 8,320 in 2022 to 9,615 in 2023, indicating an increase of 1,295 cases. Thus, the escalating prevalence of infectious diseases is set to steer the growth of the multidrug-resistant bacteria market._x000D_

_x000D_

The vyndaqel market covered in this report is segmented – _x000D_

_x000D_

1) By Product Type: Vyndaqel (Tafamidis 20 mg), Vyndamax (Tafamidis 61 mg)_x000D_

2) By Disease Type: Familial Amyloid Polyneuropathy (FAP), Wild-Type Or Hereditary Transthyretin-Mediated Amyloidosis Cardiomyopathy (ATTR-CM)_x000D_

3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies_x000D_

_x000D_

Subsegments:_x000D_

1) By Vyndaqel (Tafamidis 20 mg): Oral Tablets, Oral Solution _x000D_

2) By Vyndamax (Tafamidis 61 mg): Oral Capsules, Oral Suspension_x000D_

_x000D_

#Which Firms Are Considered Leaders In The Multidrug Resistant Bacteria Market Space?#_x000D_

Major companies operating in the vyndaqel market are Pfizer Inc. _x000D_

_x000D_

https://www.thebusinessresearchcompany.com/report/vyndaqel-global-market-report_x000D_

_x000D_

#What Role Do Regional Policies And Investments Play In Multidrug Resistant Bacteria Market Expansion?#_x000D_

North America was the largest region in the vyndaqel market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vyndaqel market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=21321&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_